These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 6835675)
1. [Hemocytological classification, clinical staging and polychemotherapy of multiple myeloma]. István L; Karl W; Michael H; Günter A; Kelényi G; Várbíró M; Dieter R Orv Hetil; 1983 Feb; 124(6):313-9. PubMed ID: 6835675 [No Abstract] [Full Text] [Related]
2. [New aspects in the clinical course determination and therapy in multiple myeloma]. Ludwig H; Pietschmann H Acta Med Austriaca; 1979; 6(5):255-60. PubMed ID: 555224 [TBL] [Abstract][Full Text] [Related]
3. Multiple myeloma: a therapeutic enigma. Hoogstraten B Am J Clin Oncol; 1982 Feb; 5(1):13-9. PubMed ID: 7081135 [TBL] [Abstract][Full Text] [Related]
4. [Reclassification of multiple myeloma and calculation of the myelomatous mass as prognostic and therapeutic indications]. Ricci C; Coscia GC; Uberti M; Discalzi G; Racca P Recenti Prog Med; 1982 Apr; 72(4):482-99. PubMed ID: 7146598 [No Abstract] [Full Text] [Related]
5. [Treatment of multiple myeloma]. Clément F Schweiz Med Wochenschr; 1986 Feb; 116(8):230-9. PubMed ID: 3082003 [TBL] [Abstract][Full Text] [Related]
6. Treatment of plasma cell myeloma. Bergsagel DE Annu Rev Med; 1979; 30():431-43. PubMed ID: 162450 [No Abstract] [Full Text] [Related]
7. [The multiple myeloma--current view and perspectives]. Knop S Med Monatsschr Pharm; 2014 Mar; 37(3):84-92; quiz 93-4. PubMed ID: 24741848 [TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy of multiple bone myeloma. Prognostic features and response criteria (First part) (author's transl)]. Bataille R; Morlock G; Rosenberg F; Sany J; Serre H Sem Hop; 1979 Sep 8-15; 55(27-30):1267-70. PubMed ID: 228397 [TBL] [Abstract][Full Text] [Related]
10. Multiple myeloma: a tailored therapy for elderly patients. Pileri A; Palumbo A; Boccadoro M Hematol Oncol; 1993; 11 Suppl 1():67-72. PubMed ID: 8486344 [No Abstract] [Full Text] [Related]
11. Second International Workshop on Myeloma: advances in biology and therapy of multiple myeloma. Barlogie B; Alexanian R Cancer Res; 1989 Dec; 49(24 Pt 1):7172-5. PubMed ID: 2479477 [No Abstract] [Full Text] [Related]
12. [Prognostic factors in multiple myeloma]. Boccadoro M; Bianchi A; Dianzani U; Frieri R; Gallone G; Massaia M; Omede P; Palumbo A; Pileri A Haematologica; 1989 Oct; 74(5 Suppl):347-57. PubMed ID: 2512219 [No Abstract] [Full Text] [Related]
13. [Interferon therapy in multiple myeloma]. Micksche M Wien Med Wochenschr; 1993; 143(16-17):425-8. PubMed ID: 8273366 [TBL] [Abstract][Full Text] [Related]
14. [Characteristics of drug resistance of tumor plasmocytes in vitro in patients with multiple myeloma differently responsive to chemotherapy]. Golenkov AK; Trifonova EV; Kataeva EV; Kil'diushevskiĭ AV; Lutskaia TD; Zariad'eva EA; Nazarova IN; Lukashina MN; Zabotina TN; Mikhaĭlova IN; Inshakov AN; Logacheva NP; Baryshnikov AIu Ter Arkh; 2000; 72(8):38-41. PubMed ID: 11019426 [TBL] [Abstract][Full Text] [Related]
15. Biology and therapy of multiple myeloma in 1996. Barlogie B; Jagannath S; Epstein J; Munshi N; Siegel D; Desikan KR; Feinman R; Hsu PL; von Bremen K; Tricot G Semin Hematol; 1997 Jan; 34(1 Suppl 1):67-72. PubMed ID: 9122748 [TBL] [Abstract][Full Text] [Related]
16. Multiple myeloma: new staging systems for diagnosis, prognosis and response evaluation. Rajkumar SV; Buadi F Best Pract Res Clin Haematol; 2007 Dec; 20(4):665-80. PubMed ID: 18070712 [TBL] [Abstract][Full Text] [Related]
17. [Comments on the therapeutic approach in myeloma]. Paule B; Médicis P; Clerc D; Ellrodt A; Bisson M; Massias P Rev Rhum Mal Osteoartic; 1986 Apr; 53(4):269-75. PubMed ID: 3526525 [No Abstract] [Full Text] [Related]
18. The biological and clinical features of human myeloma. Pileri A; Conte PF Haematologica; 1977 Apr; 62(2):202-20. PubMed ID: 406176 [No Abstract] [Full Text] [Related]